Hint mode is switched on Switch off
For swift navigation between sections

International bonds: Gilead Sciences, 1.65% 1oct2030, USD
US375558BY84

Download
Copy issue information to clipboard
Copy issue information to clipboard
Copy

Trace-eligible, Senior Unsecured

Issue
Issuer
  • M
    -
    ***
  • S&P
    -
    ***
  • F
    -
    -
Status
Outstanding
Amount
1,000,000,000 USD
Placement
***
Early redemption
*** (-)
Country of risk
USA
Current coupon
***%
Price
***%
Yield / Duration
-
Corporate Actions Issuer news
Add issue to Watchlist
{{ watchlistErrorMsg }}
Adding issue to the Watchlist is not possible because there are no quotes from exchanges for it.
DATA PLATFORM FOR FINANCIAL MARKET PROFESSIONALS AND INVESTORS
  • High performance interface for global bond market screening
  • Full information on close to 400,000 bonds from 180 countries
  • 100% coverage of Eurobonds worldwide
  • Over 300 primary sources of prices
  • Ratings data from all international and local ratings agencies
  • Stock market data from 60 world trading floors
  • Intuitive, high speed user interface
  • Data access via the website, mobile application and add-in for Microsoft Excel

Trading chart

Stock exchange selection
Stock exchange selection
More about Cbonds Estimation
Data display in a chart | table
Data display in a chart | table
Work with the chart: switching the price, period, issue comparison
Work with the chart: switching the price, period, issue comparison
Download the chart in a convenient format
More than 2,500 records have been found, please specify your request
* Data is not available within the selected subscription
Latest data on
Quotes from market participants are indicative

Stock exchange and OTC quotes

Issue information

Profile
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company primary areas of focus include HIV, AIDS, liver disease, and ...
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company primary areas of focus include HIV, AIDS, liver disease, and serious cardiovascular and respiratory conditions.
  • Borrower
    Go to the issuer page
    Gilead Sciences
  • Full issuer name
    Gilead Sciences Inc
  • Sector
    corporate
  • Industry
    Healthсare
Volume
  • Amount
    1,000,000,000 USD
  • Outstanding face value amount
    1,000,000,000 USD
Nominal
  • Minimum Settlement Amount
    1,000 USD
  • Outstanding face value
    *** USD
  • Par amount, integral multiple
    *** USD
  • Nominal
    1,000 USD

Cash flow parameters

  • Reference rate
    ***
  • Coupon Rate
    ***
  • Day count fraction
    ***
  • Interest Accrual Date
    ***
  • Coupon frequency
    *** time(s) per year
  • Payment currency
    ***
  • Delay days
    *** days
  • Maturity date
    ***
  • Early redemption date
    ***

Cash flow

Calculations for international bonds are made according to the minimum trading lot

Early redemption terms

***

DATA PLATFORM FOR FINANCIAL MARKET PROFESSIONALS AND INVESTORS
  • High performance interface for global bond market screening
  • Full information on close to 400,000 bonds from 180 countries
  • 100% coverage of Eurobonds worldwide
  • Over 300 primary sources of prices
  • Ratings data from all international and local ratings agencies
  • Stock market data from 60 world trading floors
  • Intuitive, high speed user interface
  • Data access via the website, mobile application and add-in for Microsoft Excel

Placement

  • Placement method
    Open subscription
  • Placement type
    Public
  • Order book
    *** (***) - *** (***)
  • Coupon (Yield) Guidance
    ***% - ***% (*** - ***%)
  • Issuer rating on issue date (M/S&P/F)
    - / *** / -
  • Placement
    *** - ***
  • Initial issue price (yield)
    (***%)
  • Bids
    *** USD
  • Number of bids
    ***
  • Geographic breakdown
    ***
  • Investor breakdown
    ***
  • Listing
    ***
Participants
  • Bookrunner
    ***, ***, ***, ***, ***, ***
  • Depository
    ***, ***, ***

Conversion and exchange

  • Convertion date
    ***
  • Initial premium
    ***%
  • Convertible until
    ***
  • Lock-up
    *** days
  • Conversion terms
    ***

Additional information

***

Latest issues

Stocks

Identifiers

  • Registration
    ***
  • Date of program registration
    ***
  • ISIN
    ***
  • CUSIP
    ***
  • CUSIP 144A
    ***
  • CFI
    DBFNGR
  • FIGI
    BBG00XKL4C07
  • WKN
    A2824R
  • Ticker
    GILD 1.65 10/01/30
  • Type of security by CBR
    ***

Ratings

Issue ratings
Issuer ratings

Bond classification

  • Senior Unsecured
  • Registered
  • Non-documentary bonds
  • Coupon bonds
  • Trace-eligible
  • Amortization
  • Callable
  • CDO
  • Convertible
  • Dual currency bonds
  • Floating rate
  • For qualified investors
  • Foreign bonds
  • Green bonds
  • Indexed
  • Supranational bond issues
  • Mortgage bonds
  • Perpetual
  • Payment-in-kind
  • Non-Marketable Securities
  • Redemption Linked
  • Restructuring
  • Retail bonds
  • Covered
  • Securitization
  • Structured product
  • Subordinated
  • Sukuk

Restructuring

***

***

Holders